(INCY) Incyte - Performance 11.6% in 12m
Compare INCY with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-23.04%
#49 in Group
Rel. Strength
66.30%
#2575 in Universe
Total Return 12m
11.64%
#37 in Group
Total Return 5y
-26.77%
#54 in Group
P/E 404
100th Percentile in Group
P/E Forward 10.0
42th Percentile in Group
PEG 0.39
70th Percentile in Group
FCF Yield 2.45%
81th Percentile in Group
12m Total Return: INCY (11.6%) vs XBI (-11%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
ABBV NYSE AbbVie |
-2.97% | 17.7% | 234% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
UTHR NASDAQ United Therapeutics |
0.72% | 36.6% | 226% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
-3.97% | 23.4% | 39.7% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
AMGN NASDAQ Amgen |
-1.63% | 14.1% | 68.5% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
LONN SW Lonza |
-7.89% | 0.58% | 37% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
NBIX NASDAQ Neurocrine Biosciences |
-5.39% | -21.4% | 18.7% | 33.6 | 22.8 | 0.27 | 61.5% | 31.6% |
BIM PA Biomerieux |
1.3% | 15.8% | 12.1% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
KMDA NASDAQ Kamada |
1.65% | 24.1% | 14.1% | 27 | 25 | 1 | 58.7% | 15% |
Performance Comparison: INCY vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for INCY
Total Return (including Dividends) | INCY | XBI | S&P 500 |
---|---|---|---|
1 Month | -11.29% | -5.85% | -3.01% |
3 Months | -10.36% | -11.95% | -3.15% |
12 Months | 11.64% | -11.00% | 10.19% |
5 Years | -26.77% | 0.65% | 129.24% |
Trend Score (consistency of price movement) | INCY | XBI | S&P 500 |
1 Month | -69.7% | -59.8% | -5.5% |
3 Months | -60.8% | -70.5% | -58.4% |
12 Months | 72.9% | -6.9% | 84.1% |
5 Years | -76.4% | -50% | 84.4% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #103 | -5.78% | -8.54% |
3 Month | #56 | 1.81% | -7.44% |
12 Month | #36 | 25.4% | 1.32% |
5 Years | #55 | -27.2% | -68.1% |
FAQs
Does INCY Incyte outperforms the market?
Yes,
over the last 12 months INCY made 11.64%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.00%.
Over the last 3 months INCY made -10.36%, while XBI made -11.95%.
Over the last 3 months INCY made -10.36%, while XBI made -11.95%.
Performance Comparison INCY vs Indeces and Sectors
INCY vs. Indices INCY is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 2.47% | -8.28% | -7.71% | 1.45% |
US NASDAQ 100 | QQQ | 3.45% | -7.23% | -6.94% | 3.04% |
US Dow Jones Industrial 30 | DIA | 2.27% | -9.15% | -8.63% | 2.13% |
German DAX 40 | DAX | 3.77% | -7.91% | -24.5% | -10.1% |
Shanghai Shenzhen CSI 300 | CSI 300 | 2.76% | -11.5% | 7.52% | 2.52% |
Hongkong Hang Seng | HSI | 0.50% | -14.1% | 1.51% | -5.69% |
India NIFTY 50 | INDA | 1.44% | -19.2% | 2.64% | 10.9% |
Brasil Bovespa | EWZ | 2.36% | -19.6% | 0.29% | 23.4% |
INCY vs. Sectors INCY is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 4.01% | -7.48% | -15.8% | -7.57% |
Consumer Discretionary | XLY | 1.71% | -7.46% | -11.1% | -2.42% |
Consumer Staples | XLP | -0.32% | -9.45% | -8.55% | 0.61% |
Energy | XLE | 1.38% | -19.3% | -13.3% | 10.8% |
Financial | XLF | 1.99% | -8.59% | -19.9% | -10.6% |
Health Care | XLV | 2.05% | -8.13% | -3.01% | 9.95% |
Industrial | XLI | 2.16% | -10.6% | -7.0% | 3.11% |
Materials | XLB | 1.37% | -11.8% | 0.40% | 15.6% |
Real Estate | XLRE | 0.43% | -8.60% | -4.59% | -1.72% |
Technology | XLK | 3.60% | -7.28% | -2.59% | 9.63% |
Utilities | XLU | -0.82% | -12.1% | -6.83% | -13.6% |
Aerospace & Defense | XAR | 3.07% | -12.6% | -11.6% | -9.29% |
Biotech | XBI | 7.03% | -5.44% | 9.99% | 22.6% |
Homebuilder | XHB | 1.97% | -11.4% | 11.7% | 19.3% |
Retail | XRT | 0.17% | -10.8% | -3.63% | 16.4% |